Clinical Trial Update: Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omega-3 fatty acids as monotherapy in children and adolescents with autism spectrum disorder was terminated; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorder (ASD) | Phase 2 | Status: TERMINATED | Results posted: 2014-09-22